Stephens Investment Management Group LLC Makes New $4.69 Million Investment in Simulations Plus, Inc. $SLP

Key Points

• Stephens Investment Management Group LLC has made a new investment of approximately $4.69 million in Simulations Plus, acquiring 268,576 shares, which represents about 1.33% of the company.
• Other institutional investors have also increased their stakes in Simulations Plus, with various firms reporting growth in their positions during the second quarter.
• Analysts currently have a consensus rating of "Hold" for Simulations Plus, with price targets averaging around $24.40, despite a recent downturn in stock performance.

Stephens Investment Management Group LLC acquired a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 268,576 shares of the technology company's stock, valued at approximately $4,687,000. Stephens Investment Management Group LLC owned about 1.33% of Simulations Plus at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Stephens Inc. AR grew its position in Simulations Plus by 5.2% during the 2nd quarter. Stephens Inc. AR now owns 99,339 shares of the technology company's stock worth $1,733,000 after acquiring an additional 4,900 shares during the last quarter. Mutual of America Capital Management LLC grew its position in Simulations Plus by 8.7% during the 2nd quarter. Mutual of America Capital Management LLC now owns 92,888 shares of the technology company's stock worth $1,621,000 after acquiring an additional 7,440 shares during the last quarter. Values First Advisors Inc. grew its position in Simulations Plus by 46.4% during the 2nd quarter. Values First Advisors Inc. now owns 57,372 shares of the technology company's stock worth $1,001,000 after acquiring an additional 18,184 shares during the last quarter. North Star Investment Management Corp. grew its position in Simulations Plus by 7.3% during the 2nd quarter. North Star Investment Management Corp. now owns 56,875 shares of the technology company's stock worth $992,000 after acquiring an additional 3,875 shares during the last quarter. Finally, Kopion Asset Management LLC grew its position in Simulations Plus by 22.7% during the 2nd quarter. Kopion Asset Management LLC now owns 156,401 shares of the technology company's stock worth $2,729,000 after acquiring an additional 28,980 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on SLP. Zacks Research upgraded Simulations Plus to a "hold" rating in a research report on Tuesday, August 12th. Weiss Ratings restated a "sell (d-)" rating on shares of Simulations Plus in a research note on Wednesday, October 8th. Cowen assumed coverage on Simulations Plus in a research note on Tuesday, September 30th. They issued a "hold" rating for the company. William Blair restated an "outperform" rating on shares of Simulations Plus in a research note on Tuesday, July 15th. Finally, KeyCorp cut Simulations Plus from an "overweight" rating to a "sector weight" rating in a research note on Tuesday, July 15th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Simulations Plus currently has a consensus rating of "Hold" and a consensus price target of $24.40.

Simulations Plus Price Performance

Shares of NASDAQ:SLP opened at $17.62 on Thursday. The company has a market cap of $354.69 million, a P/E ratio of -5.59 and a beta of 0.99. Simulations Plus, Inc. has a 1 year low of $12.39 and a 1 year high of $37.67. The stock's fifty day moving average price is $14.96 and its 200-day moving average price is $20.63.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.